<SEC-DOCUMENT>0001062993-16-007123.txt : 20160115
<SEC-HEADER>0001062993-16-007123.hdr.sgml : 20160115
<ACCEPTANCE-DATETIME>20160115154947
ACCESSION NUMBER:		0001062993-16-007123
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20160115
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20160115
DATE AS OF CHANGE:		20160115

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LEXARIA CORP.
		CENTRAL INDEX KEY:			0001348362
		STANDARD INDUSTRIAL CLASSIFICATION:	METAL MINING [1000]
		IRS NUMBER:				202000871
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0831

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-52138
		FILM NUMBER:		161345370

	BUSINESS ADDRESS:	
		STREET 1:		SUITE 950, 1130 WEST PENDER STREET
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V6E 4A4
		BUSINESS PHONE:		604-602-1675

	MAIL ADDRESS:	
		STREET 1:		SUITE 950, 1130 WEST PENDER STREET
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V6E 4A4

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Lexaria Corp.
		DATE OF NAME CHANGE:	20051229
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
   <TITLE>Lexaria Corp.: Form 8-K - Filed by newsfilecorp.com</TITLE>
   <META name="HandheldFriendly" content="true">
</HEAD>

<BODY style="font-size:10pt;">

<HR noshade align="center" width=100% size=3 color="black">
<A name=page_1></A>
<P align=center><B><FONT size=5>UNITED STATES </FONT></B><BR><B><FONT
size=5>SECURITIES AND EXCHANGE COMMISSION </FONT></B><BR><B>Washington, D.C.
20549 </B></P>
<P align=center><B><FONT size=5>FORM 8-K </FONT></B></P>
<P align=center>Current Report <BR>Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934 </P>
<DIV>
<TABLE
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; "
borderColor=#000000 cellSpacing=0 cellPadding=3 width="100%" border=1>

  <TR vAlign=top>
    <TD style="BORDER-BOTTOM: #000000 1px solid" align=left colSpan=3>
    <p align="center">Date of
      Report (date of earliest event reported): <B><U>January 15, 2016
    </U></B></TD></TR>
  <TR vAlign=bottom>
    <TD align=center colSpan=3><FONT size=5><B><U>LEXARIA CORP.
      </U></B></FONT><BR>(Exact name of registrant as specified in its charter)
    </TD></TR>
  <TR vAlign=top>
    <TD align=center><B><U>Nevada </U></B><BR>(State or other
      jurisdiction of <BR>incorporation) </TD>
    <TD align=center width="33%"><B><U>000-52138
      </U></B><BR>(Commission File Number) <BR></TD>
    <TD align=center width="33%"><B><U>20-2000871 </U></B><BR>(IRS
      Employer Identification No.) <BR></TD></TR>
  <TR vAlign=top>
    <TD style="BORDER-BOTTOM: #000000 1px solid" align=left colSpan=3>
    <p align="center">&nbsp;
      #950 &#150; 1130 West Pender Street, Vancouver, British Columbia, Canada V6E
      4A4 </TD></TR>
  <TR vAlign=top>
    <TD style="BORDER-BOTTOM: #000000 1px solid" align=left
      colSpan=3>
    <p align="center">Registrant's&nbsp;&nbsp;telephone number, including area code:
      <B><U>(604) 602-1675 </U></B>&nbsp; </TD>
    </TR>
  <TR vAlign=bottom>
    <TD style="BORDER-BOTTOM: #000000 1px solid" align=center
      colSpan=3>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD style="BORDER-BOTTOM: #000000 1px solid" align=center
      colSpan=3>(Former name or former address, if changed since last report.)
    </TD></TR></TABLE></DIV>
<P align=justify>Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions: </P>
<P align=justify>[&nbsp; ] Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425) </P>
<P align=justify>[&nbsp; ] Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a -12) </P>
<P align=justify>[&nbsp; ] Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d -2(b)) </P>
<P align=justify>[&nbsp; ] Pre-commencement communications pursuant to Rule 13e-4(c)
under Exchange Act (17 CFR 240.13e -4(c)) </P>
<HR style="PAGE-BREAK-AFTER: always" align=center width="100%" color=black
noShade SIZE=5>
<!--$$/page=--><A name=page_2></A>
<P align=justify><B>Item 7.01 Regulation FD Disclosure. </B></P>
<P align=justify>A copy of the news release announcing BUYINS.NET Consults to
Lexaria Corp to Surveil Short Sellers and Market Makers filed as exhibit 99.1 to
this current report and is hereby incorporated by reference. </P>
<P align=justify><B>TEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS. </B></P>
<TABLE
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; "
cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=top>
    <TD noWrap align=justify ><B>Exhibit No.</B> </TD>
    <TD noWrap align=justify width="90%"><B>Description</B> </TD></TR>
  <TR>
    <TD noWrap align=justify >&nbsp;</TD>
    <TD noWrap align=justify width="90%" >&nbsp;</TD></TR>
  <TR vAlign=top>
    <TD align=justify bgColor=#eeeeee ><a href="exhibit99-1.htm">99.1 </a></TD>
    <TD align=justify width="90%" bgColor=#eeeeee><a href="exhibit99-1.htm">News Release dated January 15, 2016 </a></TD></TR></TABLE><BR>
<HR style="PAGE-BREAK-AFTER: always" align=center width="100%" color=black
noShade SIZE=5>
<!--$$/page=--><A name=page_3></A>
<P align=center><B>SIGNATURES </B></P>
<P align=justify>Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized. </P>
<P align=justify>Dated: January 15, 2016 </P>
<DIV>
<TABLE
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; "
cellSpacing=0 cellPadding=0 width="50%" border=0>

  <TR vAlign=top>
    <TD align=left>&nbsp; </TD>
    <TD align=left width="80%" colSpan=2>Lexaria Corp. </TD></TR>
  <TR vAlign=top>
    <TD align=left>(Signature) </TD>
    <TD style="BORDER-BOTTOM: #000000 1px solid" align=left width="5%">By: </TD>
    <TD style="BORDER-BOTTOM: #000000 1px solid" align=left
      width="75%">&#147;<I>/s/ Chris Bunka&#148;</I> </TD></TR>
  <TR vAlign=top>
    <TD align=left>&nbsp; </TD>
    <TD align=left width="80%" colSpan=2>Chris Bunka </TD></TR>
  <TR vAlign=top>
    <TD align=left>&nbsp; </TD>
    <TD align=left width="80%" colSpan=2>CEO </TD></TR></TABLE></DIV><BR>
<HR align=center width="100%" color=black noShade SIZE=5>

</BODY>

</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
   <TITLE>Lexaria Corp.: Exhibit 99.1 - Filed by newsfilecorp.com</TITLE>
   <META name="HandheldFriendly" content="true">
</HEAD>

<BODY style="font-size:10pt;">

<HR noshade align="center" width=100% size=3 color="black">
<!--$$/page=--><A name=page_1></A>
<P align=justify><B>BUYINS.NET Consults to Lexaria Corp to Surveil Short Sellers
and Market Makers. </B></P>
<TABLE
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; "
cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=top>
    <TD width="5%"  >&nbsp;</TD>
    <TD align=left >&#149; </TD>
    <TD align=left width="90%"><B>Approximately 26 Million Total Shares
      Shorted Since August 2009</B> </TD></TR>
  <TR vAlign=top>
    <TD width="5%" >&nbsp;</TD>
    <TD align=left >&#149; </TD>
    <TD align=left width="90%"><B>Short Squeeze Expected When Stock Is Above
      $0.192 SqueezeTrigger Price</B> </TD></TR></TABLE>
<P align=justify><B>KELOWNA, BC / ACCESSWIRE / January 15, 2016 / </B>Lexaria
Corp. (<U>LXRP</U>) (CNSX:LXX) (the "Company" or "Lexaria") announced today that
BUYINS.NET, <U>http://www.buyins.net</U>, a leading provider of Regulation SHO
compliance monitoring, short sale trading statistics and market integrity
surveillance, has initiated coverage on Lexaria Corp. (OTC: LXRP) after
releasing the latest short sale data through January 14, 2016.</P>
<P align=justify>The total aggregate number of shares shorted since August 2009
is approximately 26 million shares. Approximately 40.82% of daily trading volume
is short selling. The SqueezeTrigger price for all LXRP shares shorted is
$0.192. A short squeeze is expected when the stock closes above the $0.192
SqueezeTrigger price. </P>
<P align=justify>Click here to view Report:
<U>http://www.buyins.com/reports/lxrp1-14-16.pdf</U> </P>
<P align=justify>Click here for SqueezeTrigger:
<U>http://www.buyins.com/images2/lxrpstr1-14-16.jpg</U> </P>
<P align=justify>Click here for Friction Factor:
<U>http://www.buyins.com/images2/lxrpff1-14-16.jpg</U> Friction Factor
calculates if a fair market is being made in the shares of LXRP.42% of the
previous 38 trading days have been positive or bullish-biased and 58% have been
negative or bearish-biased.</P>
<P align=justify>Regulation SHO requires bona-fide market-making activities to
include making purchases and sales in roughly comparable amounts. The Securities
and Exchange Commission has stated that bona-fide market-making DOES NOT include
activity that is related to speculative selling strategies for investment
purposes of the broker-dealer and is disproportionate to the usual market making
patterns or practices of the broker-dealer in that security. Likewise, where a
market-maker posts continually at or near the best offer, but does not also post
at or near the best bid, the market-maker's activities would not generally
qualify as bona-fide market-making. Moreover, a market-maker that continually
executes short sales away from its posted quotes would generally not be
considered to be engaging in bona-fide market-making. </P>
<P align=justify>BUYINS.NET will monitor LXRP market-makers daily for compliance
with Fair Market-Making Requirements, for an initial 6-month surveillance
period. Lexaria will always take all appropriate steps to encourage and ensure a
fair and transparent flow of information for its stakeholders. </P>

<HR style="PAGE-BREAK-AFTER: always" align=center width="100%" color=black
noShade SIZE=5>
<!--$$/page=--><A name=page_2></A>
<P align=justify><b>About Lexaria </b></P>
<P align=justify>Lexaria is a food sciences company focused on the delivery of
  active compounds that can behave as superfoods through its proprietary infusion
  technologies. Lexaria&#146;s technology enables higher bioavailability rates for CBD;
  THC; NSAIDs; Nicotine and other molecules than is possible without lipophilic
  enhancement technology. The Company uses innovative technology to deliver unique
  food experiences. www.lexarienergy.com </P>
<P align=justify><B>About BUYINS.NET </B></P>
<P align=justify>BUYINS.NET, <U>http://www.buyins.net</U>, monitors trading in
all US stocks in real time and maintains massive databases of short sale and
naked short sale time and sales data, short squeeze SqueezeTrigger prices,
market-maker price movements, shareholder data, statistical data on earnings,
sector correlation, seasonality, hedge fund trading strategies and comparable
valuations. </P>
<P align=justify>FOR FURTHER INFORMATION PLEASE CONTACT: </P>
<P align=justify>Lexaria Corp.<BR>Chris Bunka <BR>Chairman &amp; CEO<BR>(250)
765-6424 </P>
<P align=justify>BUYINS.NET <BR>Thomas Ronk <BR>800-715-9999 <BR>tom@buyins.net
<BR><U>http://www.buyins.net</U> </P>
<P align=justify><B>DISCLAIMER: </B></P>
<P align=justify>BUYINS.NET is not a registered investment adviser and nothing
contained in any materials should be construed as a recommendation to buy or
sell any securities. An affiliate of Lexaria Corp. has paid $1,167 per month for
six months of data provided in this and ongoing reports. LXRP believes the
information and data provided by buyins.net is accurate but has not verified it
and cautions all interested parties to verify data prior to making any
decisions. Please read our report and visit http://www.buyins.net, for complete
risks and disclosures. </P>

<HR style="PAGE-BREAK-AFTER: always" align=center width="100%" color=black
noShade SIZE=5>
<!--$$/page=--><A name=page_3></A>
<P align=justify><b>FORWARD-LOOKING STATEMENTS </b></P>
<P align=justify>This release includes forward-looking statements. Statements
  which are not historical facts are forward-looking statements. The Company makes
  forward-looking public statements concerning its expected future financial
  position, results of operations, cash flows, financing plans, business strategy,
  products and services, competitive positions, growth opportunities, plans and
  objectives of management for future operations, including statements that
  include words such as "anticipate," "if," "believe," "plan," "estimate,"
  "expect," "intend," "may," "could," "should," "will," and other similar
  expressions are forward-looking statements, including but not limited to: the
  provision of any significant investor relations or media relations services.
  Such forward-looking statements are estimates reflecting the Company's best
  judgment based upon current information and involve a number of risks and
  uncertainties, and there can be no assurance that other factors will not affect
  the accuracy of such forward-looking statements. Access to capital, or lack
  thereof, is a major risk and there is no assurance that the Company will be able
  to raise required working capital. Factors which could cause actual results to
  differ materially from those estimated by the Company include, but are not
  limited to, government regulation, managing and maintaining growth, the effect
  of adverse publicity, litigation, competition, the patent application and
  approval process and other factors which may be identified from time to time in
  the Company's public announcements and filings. There is no assurance that
  existing capital is sufficient for the Company's needs or that it will not need
  to attempt to raise additional capital. There is no assurance that any planned
  corporate activity, business venture, or initiative will be pursued, or if
  pursued, will be successful. There is no assurance that approximately 26 million
  shares of LXRP common stock has been shorted since 2009, and no knowledge that
  any shorting that has occurred is illegal or contrary to various regulations.
  Lexaria has not independently verified the data provided by any third party
  including <U>www.buyins.net</U> There is no assurance that any of Lexaria's
  postulated uses, benefits, or advantages for the patent-pending technology will
  in fact be realized in any manner or in any part.</P>
<P align=justify><I>The CSE has not reviewed and does not accept responsibility
for the adequacy or accuracy of this release.</I> </P>
<HR align=center width="100%" color=black noShade SIZE=5>

</BODY>

</HTML>

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
